Literature DB >> 34511831

Percutaneous Needle Fasciotomy versus Collagenase Injection for Dupuytren's Contracture: A Systematic Review of Comparative Studies.

Takashi Hirase1, Rishi Suresh1, Michael O Cotton1, Alex Han1, Matthew B Burn1, Joshua D Harris1, Shari R Liberman1.   

Abstract

Introduction  The purpose of this study was to review and compare clinical outcomes between percutaneous needle fasciotomy (PNF) and collagenase Clostridium histolyticum (CCH) injection for the treatment of Dupuytren's contracture. Materials and Methods  A systematic review was performed including all level I-III evidence studies investigating the clinical outcomes of PNF and CCH injection in the treatment of Dupuytren's contracture. Results  Five studies (278 CCH patients, 225 PNF patients; 285 CCH fingers, 246 PNF fingers, 405 males, and 98 females) were analyzed. Two randomized studies were level I evidence, one randomized study was level II, and two nonrandomized studies were level III. Two studies analyzed a total of 205 patients, each demonstrating statistically superior outcomes in one outcome measure (contracture improvement and Michigan Hand Questionnaire (MHQ) satisfaction subscore) with PNF, while the remaining three studies demonstrated no significant differences in outcomes between the two techniques. Three studies reported a statistically higher rate of minor complications (local pain, edema, ecchymosis, lymphadenopathy, pruritis) with CCH, while the remaining two studies demonstrated no significant difference in complication rates. Conclusion  For the treatment of Dupuytren's contracture, there is some evidence that suggests superior clinical outcomes of PNF compared with CCH and a higher minor complication rate with CCH. Society of Indian Hand & Microsurgeons. All rights reserved. Thieme Medical and Scientific Publishers Pvt. Ltd., A-12, 2nd Floor, Sector 2, Noida-201301 UP, India.

Entities:  

Keywords:  Dupuytren’s contracture; collagenase; contracture; percutaneous fasciotomy

Year:  2020        PMID: 34511831      PMCID: PMC8426042          DOI: 10.1055/s-0040-1721876

Source DB:  PubMed          Journal:  J Hand Microsurg        ISSN: 0974-3227


  38 in total

Review 1.  How to write a systematic review.

Authors:  Joshua D Harris; Carmen E Quatman; M M Manring; Robert A Siston; David C Flanigan
Journal:  Am J Sports Med       Date:  2013-08-07       Impact factor: 6.202

2.  Surgical complications associated with fasciectomy for dupuytren's disease: a 20-year review of the English literature.

Authors:  Keith Denkler
Journal:  Eplasty       Date:  2010-01-27

3.  Comparative Effectiveness of Percutaneous Needle Aponeurotomy and Limited Fasciectomy for Dupuytren's Contracture: A Multicenter Observational Study.

Authors:  Chao Zhou; Ruud W Selles; Harm P Slijper; Reinier Feitz; Yara van Kooij; Thybout M Moojen; Steven E R Hovius
Journal:  Plast Reconstr Surg       Date:  2016-10       Impact factor: 4.730

4.  Injectable collagenase Clostridium histolyticum: a new nonsurgical treatment for Dupuytren's disease.

Authors:  David Gilpin; Stephen Coleman; Stephen Hall; Anthony Houston; Jeff Karrasch; Nigel Jones
Journal:  J Hand Surg Am       Date:  2010-12       Impact factor: 2.230

Review 5.  Needle aponeurotomy in Dupuytren's disease.

Authors:  Johann Beaudreuil; Henri Lellouche; Philippe Orcel; Thomas Bardin
Journal:  Joint Bone Spine       Date:  2011-05-05       Impact factor: 4.929

6.  Dupuytren's contracture: an analysis of outcomes of percutaneous needle fasciotomy versus open fasciectomy.

Authors:  Jason T Toppi; Leisel Trompf; Nicolas R Smoll; Vivian Lim; Katrina Smith; Michael W Findlay; David J Hunter-Smith
Journal:  ANZ J Surg       Date:  2014-01-20       Impact factor: 1.872

Review 7.  Advances in the management of Dupuytren disease: collagenase.

Authors:  Vincent R Hentz; Andrew J Watt; Shaunak S Desai; Catherine Curtin
Journal:  Hand Clin       Date:  2012-09-18       Impact factor: 1.907

8.  ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions.

Authors:  Jonathan Ac Sterne; Miguel A Hernán; Barnaby C Reeves; Jelena Savović; Nancy D Berkman; Meera Viswanathan; David Henry; Douglas G Altman; Mohammed T Ansari; Isabelle Boutron; James R Carpenter; An-Wen Chan; Rachel Churchill; Jonathan J Deeks; Asbjørn Hróbjartsson; Jamie Kirkham; Peter Jüni; Yoon K Loke; Theresa D Pigott; Craig R Ramsay; Deborah Regidor; Hannah R Rothstein; Lakhbir Sandhu; Pasqualina L Santaguida; Holger J Schünemann; Beverly Shea; Ian Shrier; Peter Tugwell; Lucy Turner; Jeffrey C Valentine; Hugh Waddington; Elizabeth Waters; George A Wells; Penny F Whiting; Julian Pt Higgins
Journal:  BMJ       Date:  2016-10-12

9.  Collagenase injections for Dupuytren's disease: prospective cohort study assessing 2-year treatment effect durability.

Authors:  Anna Lauritzson; Isam Atroshi
Journal:  BMJ Open       Date:  2017-03-15       Impact factor: 2.692

10.  Collagenase Clostridium Histolyticum Injection for Dupuytren Contracture: 2-Year Follow-up.

Authors:  Suresh K Nayar; Dennis Pfisterer; John V Ingari
Journal:  Clin Orthop Surg       Date:  2019-08-12
View more
  1 in total

1.  Selection in Scopus.

Authors:  J Terrence Jose Jerome
Journal:  J Hand Microsurg       Date:  2022-02-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.